Jeronselvain Successfully Concludes 'PDRN Hands-on Course'

Jeronselvain, a company specializing in the production of prescription drugs, announced on September 15 that it had successfully concluded the 'PDRN Total Hands-on Course.'

This seminar provided an opportunity to share the clinical application potential of the company’s core ingredient, polydeoxyribonucleotide (PDRN), with medical professionals, and combined regenerative medicine theory and practical training in the dental field to offer hands-on clinical techniques.

According to the company, the seminar featured a variety of discussions and exchanges about PDRN, with numerous dental specialists and industry professionals in attendance, confirming the efficacy of 'Selvain Injection.'

The speakers included Lim Jongwon, Director of Best Dental Clinic; Seol Wonseok, Director of Apple Dental Clinic; Yoon Jongil, Vice President of the PDRN Immuno-Regenerative Dental Research Society and Director of Yeon Dental Clinic; Lee Deokwon, Director of The One Oral & Maxillofacial Surgery; Kim Hyungjun, Director of OFP Oral Medicine Dental Clinic; Kwon Yongdae, Professor at Kyung Hee University Dental Hospital; and Lee Sunjeong, Director of Yonsei SK Dental Clinic.

Each speaker shared applicable knowledge and expertise on topics such as: ▲Clinical case studies of PDRN in dentistry ▲You Can Do This CASE! Maximum results with minimal equipment ▲Understanding PDRN, dental clinical applications, and bone immunology, Parts 1 and 2 ▲Treatment of MRONJ using PDRN ▲Pathophysiology of temporomandibular joint disorders and PDRN injection therapy ▲PDRN pressure lift for transcrestal approach ▲The beginning of dental aesthetics: Utilizing PDRN.

This seminar also included 'PDRN Hands-on,' as well as additional sessions on 'Temporomandibular Joint Disorder (TMD) Hands-on' and 'Skin Hands-on,' providing a platform to share broader clinical application possibilities and deepen professional expertise.

Yoon Jongil, Vice President of the PDRN Immuno-Regenerative Dental Research Society, stated, "This seminar was a meaningful opportunity to confirm the clinical utility of PDRN in dentistry, while also exploring its potential expansion into temporomandibular joint and skin fields. We plan to continue various academic activities to further strengthen the capabilities of medical professionals and enhance the level of patient care."